Wu, Wence
Zhang, Xinxin
Li, Xiaoyang
Yu, Shengji
Funding for this research was provided by:
National Natural Science Foundation of China (82002848, 82002848, 82002848, 82002848)
Capital Characterized Clinical Application Research Fund of Beijing Municipal Science and Technology Commission of China (Z171100001017210, Z171100001017210, Z171100001017210, Z171100001017210)
CAMS Innovation Fund for Medical Sciences (2021-I2MI2 M-C&T-B-054, 2021-I2MI2 M-C&T-B-054, 2021-I2MI2 M-C&T-B-054, 2021-I2MI2 M-C&T-B-054)
Article History
Received: 23 March 2022
Accepted: 19 July 2022
First Online: 26 July 2022
Declarations
:
: The study was approved by the Ethics Committee of Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. All methods were carried out in accordance with relevant guidelines and regulations. All patients were informed about the purpose and procedures of the study and provided informed consent.
: Written informed consent was obtained from the patient for publication of his clinical details and/or clinical images. A copy of the consent form is available for review.
: The authors declare that they have no competing interests.